{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:39:35Z","timestamp":1789000775885,"version":"build-2803163510"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/sla.0b013e318262b218","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T07:43:38Z","timestamp":1344325418000},"page":"490-505","source":"Crossref","is-referenced-by-count":102,"title":["Posthepatectomy HBV Reactivation in Hepatitis B\u2013Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels"],"prefix":"10.1097","volume":"257","author":[{"given":"Gang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C. H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yee","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-ya","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210203","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.","volume":"14","author":"Gomaa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R2-18-20210203","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma.","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"R3-18-20210203","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0168-8278(03)00140-5","article-title":"Hepatitis B virus and hepatocellular carcinoma.","volume":"39","author":"Bruix","year":"2003","journal-title":"J Hepatol"},{"key":"R4-18-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R5-18-20210203","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease.","volume":"351","author":"Liaw","year":"2004","journal-title":"N Engl J Med"},{"key":"R6-18-20210203","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2010.03.006","article-title":"Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.","volume":"8","author":"Chu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-18-20210203","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1028::AID-CNCR4>3.0.CO;2-A","article-title":"Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.","volume":"82","author":"Lise","year":"1998","journal-title":"Cancer"},{"key":"R8-18-20210203","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archsurg.1994.01420310070012","article-title":"Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.","volume":"129","author":"Chen","year":"1994","journal-title":"Arch Surg"},{"key":"R9-18-20210203","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00000658-200203000-00009","article-title":"Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.","volume":"235","author":"Poon","year":"2002","journal-title":"Ann Surg"},{"key":"R10-18-20210203","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O","article-title":"Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.","volume":"89","author":"Poon","year":"2000","journal-title":"Cancer"},{"key":"R11-18-20210203","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.surg.2006.06.028","article-title":"Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.","volume":"141","author":"Shah","year":"2007","journal-title":"Surgery"},{"key":"R12-18-20210203","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1023\/A:1024759606402","article-title":"Fibrosis and inflammatory activity in noncancerous tissue and mitotic index of cancer tissue in patients with hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.","volume":"48","author":"Nanashima","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R13-18-20210203","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1572-0241.2008.01872.x","article-title":"Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.","volume":"103","author":"Hung","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R15-18-20210203","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4321\/S1130-01082010000900006","article-title":"Hepatitis B reactivation and current clinical impact.","volume":"102","author":"Alvarez-Suarez","year":"2010","journal-title":"Rev Esp Enferm Dig"},{"key":"R16-18-20210203","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.surge.2010.07.011","article-title":"Surgery induced immunosuppression.","volume":"9","author":"Hogan","year":"2011","journal-title":"Surgeon"},{"key":"R17-18-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000658-200101000-00020","article-title":"Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.","volume":"233","author":"Kubo","year":"2001","journal-title":"Ann Surg"},{"key":"R18-18-20210203","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R19-18-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R20-18-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"R21-18-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2002.03239.x","article-title":"Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkins lymphoma.","volume":"116","author":"Liao","year":"2002","journal-title":"Br J Haematol"},{"key":"R22-18-20210203","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1046\/j.1365-2036.2002.01364.x","article-title":"Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.","volume":"16","author":"Lim","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-18-20210203","first-page":"2925","article-title":"Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.","volume":"46","author":"Markovic","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"R24-18-20210203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00277-003-0825-8","article-title":"Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.","volume":"83","author":"Leaw","year":"2004","journal-title":"Ann Hematol"},{"key":"R25-18-20210203","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1478-3231.2004.0964.x","article-title":"Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration.","volume":"24","author":"Dai","year":"2004","journal-title":"Liver Int"},{"key":"R26-18-20210203","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmv.10430","article-title":"Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.","volume":"70","author":"Yeo","year":"2003","journal-title":"J Med Virol"},{"key":"R27-18-20210203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jhep.2004.05.014","article-title":"Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.","volume":"41","author":"Jang","year":"2004","journal-title":"J Hepatol"},{"key":"R28-18-20210203","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/annonc\/mdh430","article-title":"Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.","volume":"15","author":"Yeo","year":"2004","journal-title":"Ann Oncol"},{"key":"R29-18-20210203","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/jhep.2002.35068","article-title":"Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation.","volume":"36","author":"Lau","year":"2002","journal-title":"Hepatology"},{"key":"R30-18-20210203","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2004.05.161","article-title":"Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.","volume":"22","author":"Yeo","year":"2004","journal-title":"J Clin Oncol"},{"key":"R31-18-20210203","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood.V99.7.2324","article-title":"High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation.","volume":"99","author":"Lau","year":"2002","journal-title":"Blood"},{"key":"R32-18-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1352-0504.2003.00467.x","article-title":"High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.","volume":"11","author":"Zhong","year":"2004","journal-title":"J Viral Hepat"},{"key":"R33-18-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1072-7515(01)01011-0","article-title":"The immunologic response to injury.","volume":"193","author":"Mannick","year":"2001","journal-title":"J Am Coll Surg"},{"key":"R34-18-20210203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1067\/mhn.2000.104669","article-title":"Immunomodulating effects of surgical intervention in tumors of the head and neck.","volume":"123","author":"Dietz","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R35-18-20210203","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archsurg.135.10.1141","article-title":"Apoptosis and surgical trauma: dysregulated expression of death and survival factors on peripheral lymphocytes.","volume":"135","author":"Delogu","year":"2000","journal-title":"Arch Surg"},{"key":"R36-18-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s004230050200","article-title":"Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications.","volume":"384","author":"Sietses","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"R37-18-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.21024","article-title":"A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.","volume":"43","author":"Jang","year":"2006","journal-title":"Hepatology"},{"key":"R38-18-20210203","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.2000.18.5.1094","article-title":"Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.","volume":"18","author":"Poon","year":"2000","journal-title":"J Clin Oncol"},{"key":"R39-18-20210203","first-page":"1078","article-title":"Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.","volume":"50","author":"Sonoyama","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R40-18-20210203","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2168.2001.01732.x","article-title":"Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.","volume":"88","author":"Nagasue","year":"2001","journal-title":"Br J Surg"},{"key":"R41-18-20210203","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2007.06.019","article-title":"Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.","volume":"47","author":"Sun","year":"2007","journal-title":"J Hepatol"},{"key":"R42-18-20210203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2007.119859","article-title":"Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes BC, specific mutations of enhancer IIcore promoterprecore regions and HBV DNA levels.","volume":"57","author":"Yuen","year":"2008","journal-title":"Gut"},{"key":"R43-18-20210203","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1440-1746.2004.03360.x","article-title":"High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.","volume":"19","author":"Ohata","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"R44-18-20210203","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.","volume":"51","author":"Wu","year":"2009","journal-title":"J Hepatol"},{"key":"R45-18-20210203","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"R46-18-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000050093","article-title":"Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma.","volume":"18","author":"Kubo","year":"2001","journal-title":"Dig Surg"},{"key":"R47-18-20210203","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11605-010-1211-1","article-title":"High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection.","volume":"14","author":"Qu","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R48-18-20210203","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1440-1746.2010.06416.x","article-title":"Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.","volume":"25","author":"An","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R49-18-20210203","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2009.08.003","article-title":"Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.","volume":"51","author":"Hoshida","year":"2009","journal-title":"J Hepatol"},{"key":"R50-18-20210203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B.","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"R51-18-20210203","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1015-9584(08)60056-1","article-title":"Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy.","volume":"31","author":"Cheung","year":"2008","journal-title":"Asian J Surg"},{"key":"R52-18-20210203","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","article-title":"Hepatitis B virus-induced oncogenesis.","volume":"13","author":"Lupberger","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R53-18-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2003.08.010","article-title":"Etiology, natural history and treatment of hepatocellular carcinoma.","volume":"60","author":"Colombo","year":"2003","journal-title":"Antiviral Res"},{"key":"R54-18-20210203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1099\/vir.0.19650-0","article-title":"Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin.","volume":"85","author":"Pan","year":"2004","journal-title":"J Gen Virol"},{"key":"R55-18-20210203","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2003.09.026","article-title":"Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.","volume":"125","author":"Lau","year":"2003","journal-title":"Gastroenterology"},{"key":"R56-18-20210203","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1136\/gut.2005.070763","article-title":"Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.","volume":"54","author":"Hui","year":"2005","journal-title":"Gut"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000658-201303000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:40:13Z","timestamp":1618040413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000658-201303000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e318262b218","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}